Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Department of Medicine, Rhode Island Hospital and Alpert Medical School, Brown University, Providence, RI, United States.
Front Immunol. 2023 Feb 23;14:1137332. doi: 10.3389/fimmu.2023.1137332. eCollection 2023.
Peritoneal dialysis (PD) is an effective replacement therapy for end-stage renal disease patients. However, long-term exposure to peritoneal dialysate will lead to the development of peritoneal fibrosis. Epigenetics has been shown to play an important role in peritoneal fibrosis, but the role of histone deacetylases 8 (HDAC8) in peritoneal fibrosis have not been elucidated. In this research, we focused on the role and mechanisms of HDAC8 in peritoneal fibrosis and discussed the mechanisms involved.
We examined the expression of HDAC8 in the peritoneum and dialysis effluent of continuous PD patients. Then we assessed the role and mechanism of HDAC8 in peritoneal fibrosis progression in mouse model of peritoneal fibrosis induced by high glucose peritoneal dialysis fluid by using PCI-34051. In vitro, TGF-β1 or IL-4 were used to stimulate human peritoneal mesothelial cells (HPMCs) or RAW264.7 cells to establish two cell injury models to further explore the role and mechanism of HDAC8 in epithelial-mesenchymal transition (EMT) and macrophage polarization.
We found that HDAC8 expressed highly in the peritoneum from patients with PD-related peritonitis. We further revealed that the level of HDAC8 in the dialysate increased over time, and HDAC8 was positively correlated with TGF-β1 and vascular endothelial growth factor (VEGF), and negatively correlated with cancer antigen 125. In mouse model of peritoneal fibrosis induced by high glucose dialysate, administration of PCI-34051 (a selective HDAC8 inhibitor) significantly prevented the progression of peritoneal fibrosis. Treatment with PCI-34051 blocked the phosphorylation of epidermal growth factor receptor (EGFR) and the activation of its downstream signaling pathways ERK1/2 and STAT3/HIF-1α. Inhibition of HDAC8 also reduced apoptosis. In vitro, HDAC8 silencing with PCI-34051 or siRNA inhibited TGF-β1-induced EMT and apoptosis in HPMCs. In addition, continuous high glucose dialysate or IL-4 stimulation induced M2 macrophage polarization. Blockade of HDAC8 reduced M2 macrophage polarization by inhibiting the activation of STAT6 and PI3K/Akt signaling pathways.
We demonstrated that HDAC8 promoted the EMT of HPMCs via EGFR/ERK1/2/STAT3/HIF-1α, induced M2 macrophage polarization via STAT6 and PI3K/Akt signaling pathways, and ultimately accelerated the process of peritoneal fibrosis.
腹膜透析(PD)是终末期肾病患者有效的替代治疗方法。然而,长期暴露于腹膜透析液会导致腹膜纤维化的发生。表观遗传学已被证明在腹膜纤维化中发挥重要作用,但组蛋白去乙酰化酶 8(HDAC8)在腹膜纤维化中的作用尚未阐明。在这项研究中,我们专注于 HDAC8 在腹膜纤维化中的作用和机制,并讨论了涉及的机制。
我们检测了持续 PD 患者的腹膜和透析液中 HDAC8 的表达。然后,我们使用 PCI-34051 评估了 HDAC8 在高糖腹膜透析液诱导的腹膜纤维化小鼠模型中腹膜纤维化进展中的作用和机制。在体外,使用 TGF-β1 或 IL-4 刺激人腹膜间皮细胞(HPMCs)或 RAW264.7 细胞,建立两种细胞损伤模型,进一步探讨 HDAC8 在上皮间质转化(EMT)和巨噬细胞极化中的作用和机制。
我们发现 PD 相关腹膜炎患者的腹膜中 HDAC8 表达水平较高。我们进一步揭示,HDAC8 在透析液中的水平随时间推移而升高,并且 HDAC8 与 TGF-β1 和血管内皮生长因子(VEGF)呈正相关,与癌抗原 125 呈负相关。在高糖透析液诱导的腹膜纤维化小鼠模型中,给予 PCI-34051(一种选择性 HDAC8 抑制剂)可显著阻止腹膜纤维化的进展。PCI-34051 治疗阻断了表皮生长因子受体(EGFR)的磷酸化及其下游信号通路 ERK1/2 和 STAT3/HIF-1α 的激活。HDAC8 的抑制也减少了细胞凋亡。在体外,用 PCI-34051 或 siRNA 沉默 HDAC8 可抑制 TGF-β1 诱导的 HPMCs 上皮间质转化和凋亡。此外,持续高糖透析液或 IL-4 刺激诱导 M2 巨噬细胞极化。阻断 HDAC8 通过抑制 STAT6 和 PI3K/Akt 信号通路减少 M2 巨噬细胞极化。
我们证明 HDAC8 通过 EGFR/ERK1/2/STAT3/HIF-1α 促进 HPMCs 的 EMT,通过 STAT6 和 PI3K/Akt 信号通路诱导 M2 巨噬细胞极化,最终加速腹膜纤维化过程。